DEBT - Narrative (Details)							1 Months Ended									3 Months Ended	12 Months Ended
	Aug. 12, 2022 USD ($)	Aug. 11, 2022 USD ($) license	Aug. 27, 2021 USD ($) quarter covenant shares	May 04, 2021 $ / shares shares	Apr. 22, 2021 USD ($) $ / shares	Apr. 14, 2021 USD ($) $ / shares shares	Nov. 30, 2022 USD ($)	Aug. 31, 2022 license	Aug. 31, 2021 USD ($) shares	Apr. 30, 2021 USD ($)	Jan. 31, 2021 USD ($)	Oct. 31, 2020 USD ($) $ / shares shares	Sep. 30, 2019 USD ($)	Jul. 31, 2019 note $ / shares shares	Jun. 30, 2019 USD ($) $ / shares shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) entity $ / shares shares	Dec. 31, 2021 USD ($) entity $ / shares	Dec. 31, 2020 USD ($) $ / shares	Jan. 31, 2023 USD ($)	May 31, 2019
Debt Instrument [Line Items]
Loss on extinguishment of debt																	$ 2,180,000	$ 6,637,000	$ 0
Loss on extinguishment of debt, write-off of unamortized deferred financing costs																	337,000	4,981,000
Loss on extinguishment of debt, prepayment fees and additional cash interest payments																	1,843,000	1,656,000
Proceeds from issuance of debt																	84,364,000	259,500,000	101,886,000
Repayments of debt																	$ 3,143,000	$ 79,267,000	$ 19,591,000
Exercise price of warrants (in dollars per share) | $ / shares															$ 4.00		$ 3.46	$ 4.00	$ 3.81
Payments for repurchase of warrants																	$ 0	$ 4,156,000	$ 0
Warrants with $3.20 exercise price
Debt Instrument [Line Items]
Number of warrants (in shares) | shares						1,094,000								1,094,000
Exercise price of warrants (in dollars per share) | $ / shares						$ 3.20								$ 3.20
Weighted average warrant term														3 years
Payments for repurchase of warrants						$ 4,156,000				$ 4,156,000
Warrants with $4.00 exercise price
Debt Instrument [Line Items]
Number of warrants (in shares) | shares												1,250,000					3,531,000
Exercise price of warrants (in dollars per share) | $ / shares												$ 4.00					$ 4.00
Weighted average warrant term												5 years
Illinois Licenses
Debt Instrument [Line Items]
Number of licenses acquired | license		1						2
Assets acquired long-term debt		$ 2,500,000
Ohio Patient Access LLC (“OPA”)
Debt Instrument [Line Items]
Assets acquired long-term debt	$ 11,000,000
Asset acquisition, net of discount																	$ 3,010,000
Class A common stock
Debt Instrument [Line Items]
Number of warrants (in shares) | shares			3,130,000
Intrinsic value of warrants			$ 2,639,000
Shares issued upon conversion of convertible notes (in shares) | shares				37,388,000
2021 Credit Facility
Debt Instrument [Line Items]
Notes issued			210,000,000
Maximum borrowing capacity if amended			$ 275,000,000
Interest rate			9.50%
Extension term			364 days
Number of financial covenants | covenant			2
Covenant, minimum liquidity at fiscal quarter end			$ 20,000,000
Number of consecutive quarters used for covenant measurement | quarter			4
Deferred finance costs gross			$ 8,806,000
Debt																	$ 275,000,000	$ 210,000,000
2021 Credit Facility | Debt Instrument, Covenant, Period One
Debt Instrument [Line Items]
Covenant, maximum EBITDA to cash interest expense ratio																		2.00
2021 Credit Facility | Debt Instrument, Covenant, Period Three
Debt Instrument [Line Items]
Covenant, maximum EBITDA to cash interest expense ratio																2.50
2021 Credit Facility | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Prepayment penalty, percent			4750.00%
2021 Credit Facility | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Prepayment penalty, percent			2375.00%
2021 Credit Facility | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Prepayment penalty, percent			0.00%
2022 Loan
Debt Instrument [Line Items]
Line of credit facility, additional borrowing capacity if amended																$ 65,000,000
Deferred finance costs gross			$ 7,606,000
Sellers' Notes
Debt Instrument [Line Items]
Interest rate																	13.00%	13.00%
Repayments of notes payable																	$ 24,839,000
Number of acquired entitles associated with sellers notes repaid | entity																	2
Long-term debt, net																	$ 8,000,000	$ 8,000,000
Number of acquired entitles associated with sellers notes outstanding | entity																	1	1
Debt																	$ 27,606,000	$ 39,116,000
Repayments of notes																		3,143,000
Sellers' Notes | Noncontrolling Interest Acquired
Debt Instrument [Line Items]
Long-term debt, net																		3,136,000
Current portion of debt, net																		3,140,000
Debt																	3,140,000
Sellers' Notes | Illinois Licenses
Debt Instrument [Line Items]
Current portion of debt, net																	8,100,000
Sellers' Notes | Ohio Patient Access LLC (“OPA”)
Debt Instrument [Line Items]
Long-term debt, net																	8,366,000
Sellers' Notes | Subsequent Event
Debt Instrument [Line Items]
Paid in less holdback amount																				$ 39,000
Financing Agreement
Debt Instrument [Line Items]
Interest rate							10.00%
Debt																	19,364,000	0
Proceeds from issuance of debt																	19,364,000
Interests An Retention Tax Credit Claim							$ 22,800,000
Capital Construction Loan
Debt Instrument [Line Items]
Interest rate																					14.00%
Loss on extinguishment of debt									$ 355,000
Repayments of debt									11,624,000
Payment of accrued interest									1,007,000
Extinguishment of debt, prepayment penalty									375,000
July 2019 Notes
Debt Instrument [Line Items]
Interest rate														15.00%
Loss on extinguishment of debt									34,000
Repayments of debt									10,000,000
Payment of accrued interest									283,000
Number of notes issued | note														2
Ann Arbor Note
Debt Instrument [Line Items]
Interest rate													10.00%
Loss on extinguishment of debt									(290,000)
Repayments of debt											$ 500,000		$ 4,750,000
October 2020 Credit Facility
Debt Instrument [Line Items]
Interest rate												14.25%
Extension term												2 years
Loss on extinguishment of debt									3,915,000
Loss on extinguishment of debt, write-off of unamortized deferred financing costs									1,282,000
Repayments of debt									25,000,000
Payment of accrued interest									642,000
Lender expenses reimbursed									26,000
Maturity interest payment												$ 3,750,000
Extinguishment of debt, true-up payment									2,656,000
Reduction on debt interest expense									$ 49,000
Shares issued upon conversion of convertible notes (in shares) | shares									1,986,000
Debt instrument, term												3 years
Debt covenant, minimum cash balance requirement												$ 5,000,000
Debt covenant, minimum cash to consolidated fixed charge ratio												2.00
Warrant, fair value, recorded as debt discount												$ 75,000
NJ Term Loan
Debt Instrument [Line Items]
Interest rate												17.00%
Loss on extinguishment of debt									$ 2,059,000
Loss on extinguishment of debt, write-off of unamortized deferred financing costs									1,228,000
Repayments of debt									20,000,000
Payment of accrued interest									595,000
Make-whole payment									831,000
Debt covenant, maximum debt to assets ratio												0.70
NJ Real Estate Loan
Debt Instrument [Line Items]
Interest rate																			12.00%
Loss on extinguishment of debt									564,000
Loss on extinguishment of debt, write-off of unamortized deferred financing costs									105,000
Repayments of debt									4,500,000
Payment of accrued interest									39,000
Extinguishment of debt, prepayment penalty									450,000
Lender expenses reimbursed									17,000
Interest expense									$ (8,000)
2019 AWH Convertible Notes
Debt Instrument [Line Items]
Notes issued															$ 35,000,000
Number of warrants (in shares) | shares															1,969,000
Weighted average warrant term															3 years
Debt instrument, term															2 years
2019 AWH Convertible Notes | Interest Rate Period One
Debt Instrument [Line Items]
Interest rate															8.00%
2019 AWH Convertible Notes | Interest Rate Period Two
Debt Instrument [Line Items]
Interest rate															10.00%
2019 AWH Convertible Notes | Interest Rate Period Three
Debt Instrument [Line Items]
Interest rate															13.00%
2019 AWH Convertible Notes | Class A common stock
Debt Instrument [Line Items]
Conversion price (in dollars per share) | $ / shares				$ 2.96
AWH Convertible Promissory Notes
Debt Instrument [Line Items]
Shares issued upon conversion of convertible notes (in shares) | shares				28,478,000
Convertible debt, discount if offering occurs within 12 months of closing date					20.00%
Convertible debt, discount if offering occurs after 12 months of closing date					25.00%
Company valuation					$ 295,900,000
Company valuation per share (in dollars per share) | $ / shares					$ 2.96
Convertible promissory notes, period outstanding under which twelve months interest is due at conversion					12 months
AWH Convertible Promissory Notes | Affiliated Entity
Debt Instrument [Line Items]
Total debt					$ 1,000,000
2021 AWH Convertible Promissory Notes
Debt Instrument [Line Items]
Notes issued											$ 49,500,000
Convertible promissory notes, period outstanding under which twelve months interest is due at conversion				12 months
Convertible debt, discount if IPO occurs within 12 months of note issuance											20.00%
Convertible debt, discount if IPO occurs after 12 months of debt issuance but before debt maturity											25.00%
2021 AWH Convertible Promissory Notes | Interest Rate Period One
Debt Instrument [Line Items]
Interest rate											8.00%
2021 AWH Convertible Promissory Notes | Interest Rate Period Two
Debt Instrument [Line Items]
Interest rate											10.00%
2021 AWH Convertible Promissory Notes | Interest Rate Period Three
Debt Instrument [Line Items]
Interest rate											13.00%
2021 AWH Convertible Promissory Notes | Class A common stock
Debt Instrument [Line Items]
Shares issued upon conversion of convertible notes (in shares) | shares				8,910,000
Conversion price (in dollars per share) | $ / shares				$ 6.00
Term notes
Debt Instrument [Line Items]
Repayments of notes																	24,839,000	76,124,000	$ 18,020,000
HCI sellers' note
Debt Instrument [Line Items]
Repayments of notes																	$ 3,143,000		$ 1,571,000
MOCA Sellers' Note
Debt Instrument [Line Items]
Repayments of notes																		11,174,000
Hemma Sellers Notes
Debt Instrument [Line Items]
Repayments of notes																		$ 4,712,000